2-((R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)acetic acid-D4; N-[(3?,?5?,?7?))-3,7-dihydroxy-24-oxocholan-24-yl]Glycine-d4; 3?,7?-Dihydroxy-5?-cholanoylglycine-d4; Glycylursodeoxycholic Acid-d4; N-(3?,7?-Dihydroxy-5?-cholan-24-oyl)glycine-d4; N-[(3?,5?,7?)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine-d4; Ursodeoxycholylglycine-d4; Glycoursodiol-d4
Glycoursodeoxycholic-2,2,4,4-d4 Acid is a fully characterized chemical compound used as a reference standard of API Ursodiol. The standard offered is compliant with regulatory guidelines. Glycoursodeoxycholic-2,2,4,4-d4 Acid is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 2044276-17-5
